CEA as a Marker for Medullary Thyroid Carcinoma in a Patient with Colorectal Cancer

Authors

  • Parul Goyal, MBBS University of Kansas School of Medicine-Wichita Department of Internal Medicine, Wichita, KS
  • Rami Mortada, M.D. University of Kansas School of Medicine-Wichita Department of Internal Medicine, Wichita, KS
  • Rawaa Ebrahem, M.D. University of Kansas School of Medicine-Wichita Department of Internal Medicine, Wichita, KS
  • Salam Kadhem, M.D. University of Kansas School of Medicine-Wichita Department of Internal Medicine, Wichita, KS

DOI:

https://doi.org/10.17161/kjm.v9i4.8630

Keywords:

carcinoembryonic antigen, medullary thyroid cancer, MEN 2A syndrome

Metrics

Metrics Loading ...

Downloads

Published

2019-01-08

Issue

Vol. 9 No. 4 (2016)

Section

Case Reports

License

All articles in the Kansas Journal of Medicine are licensed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License (CC-BY-NC-ND 4.0). 

 

How to Cite

Goyal, P., Mortada, R., Ebrahem, R., & Kadhem, S. (2019). CEA as a Marker for Medullary Thyroid Carcinoma in a Patient with Colorectal Cancer. Kansas Journal of Medicine, 9(4), 109-110. https://doi.org/10.17161/kjm.v9i4.8630